Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 1
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. Among authors: banasiak ep. Lancet Rheumatol. 2023 Mar;5(3):e139-e150. doi: 10.1016/S2665-9913(23)00006-1. Epub 2023 Jan 23. Lancet Rheumatol. 2023. PMID: 36844970 Free PMC article.
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.
McCarter KR, Wolfgang T, Arabelovic S, Wang X, Yoshida K, Banasiak EP, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. McCarter KR, et al. Among authors: banasiak ep. Lancet Rheumatol. 2023 May;5(5):e274-e283. doi: 10.1016/s2665-9913(23)00064-4. Epub 2023 Mar 27. Lancet Rheumatol. 2023. PMID: 37841635
Interactions of anionic surfactants with methemoglobin.
Gebicka L, Banasiak E. Gebicka L, et al. Among authors: banasiak e. Colloids Surf B Biointerfaces. 2011 Mar;83(1):116-21. doi: 10.1016/j.colsurfb.2010.11.017. Epub 2010 Nov 17. Colloids Surf B Biointerfaces. 2011. PMID: 21131182
Flavonoids as reductants of ferryl hemoglobin.
Gebicka L, Banasiak E. Gebicka L, et al. Among authors: banasiak e. Acta Biochim Pol. 2009;56(3):509-13. Epub 2009 Sep 17. Acta Biochim Pol. 2009. PMID: 19774231 Free article.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TY, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: banasiak ep. Ann Rheum Dis. 2022 Dec;81(12):1742-1749. doi: 10.1136/ard-2022-222954. Epub 2022 Aug 9. Ann Rheum Dis. 2022. PMID: 35944947 Free PMC article.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TYT, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: banasiak ep. medRxiv [Preprint]. 2022 Jun 20:2022.06.19.22276599. doi: 10.1101/2022.06.19.22276599. medRxiv. 2022. PMID: 35765565 Free PMC article. Updated. Preprint.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. Among authors: banasiak ep. medRxiv [Preprint]. 2022 Oct 30:2022.10.27.22281629. doi: 10.1101/2022.10.27.22281629. medRxiv. 2022. PMID: 36324801 Free PMC article. Updated. Preprint.
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications.
Cook CE, Patel NJ, Fu X, Wang X, Kawano Y, Vanni KMM, Qian G, Banasiak E, Kowalski E, Choi HK, Zhang Y, Sparks JA, Wallace ZS. Cook CE, et al. Among authors: banasiak e. J Rheumatol. 2023 May;50(5):697-703. doi: 10.3899/jrheum.220870. Epub 2023 Jan 15. J Rheumatol. 2023. PMID: 36642428 Free article.
11 results